Cargando…
Structure-based development of three- and four-antibody cocktails against SARS-CoV-2 via multiple mechanisms
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Singapore
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005859/ https://www.ncbi.nlm.nih.gov/pubmed/33782529 http://dx.doi.org/10.1038/s41422-021-00497-7 |
| _version_ | 1783672197713231872 |
|---|---|
| author | Sun, Yao Wang, Lei Feng, Rui Wang, Nan Wang, Yuxi Zhu, Dandan Xing, Xiaorui Yang, Peng Zhang, Yanjun Li, Weimin Wang, Xiangxi |
| author_facet | Sun, Yao Wang, Lei Feng, Rui Wang, Nan Wang, Yuxi Zhu, Dandan Xing, Xiaorui Yang, Peng Zhang, Yanjun Li, Weimin Wang, Xiangxi |
| author_sort | Sun, Yao |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8005859 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer Singapore |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-80058592021-03-29 Structure-based development of three- and four-antibody cocktails against SARS-CoV-2 via multiple mechanisms Sun, Yao Wang, Lei Feng, Rui Wang, Nan Wang, Yuxi Zhu, Dandan Xing, Xiaorui Yang, Peng Zhang, Yanjun Li, Weimin Wang, Xiangxi Cell Res Letter Springer Singapore 2021-03-29 2021-05 /pmc/articles/PMC8005859/ /pubmed/33782529 http://dx.doi.org/10.1038/s41422-021-00497-7 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter Sun, Yao Wang, Lei Feng, Rui Wang, Nan Wang, Yuxi Zhu, Dandan Xing, Xiaorui Yang, Peng Zhang, Yanjun Li, Weimin Wang, Xiangxi Structure-based development of three- and four-antibody cocktails against SARS-CoV-2 via multiple mechanisms |
| title | Structure-based development of three- and four-antibody cocktails against SARS-CoV-2 via multiple mechanisms |
| title_full | Structure-based development of three- and four-antibody cocktails against SARS-CoV-2 via multiple mechanisms |
| title_fullStr | Structure-based development of three- and four-antibody cocktails against SARS-CoV-2 via multiple mechanisms |
| title_full_unstemmed | Structure-based development of three- and four-antibody cocktails against SARS-CoV-2 via multiple mechanisms |
| title_short | Structure-based development of three- and four-antibody cocktails against SARS-CoV-2 via multiple mechanisms |
| title_sort | structure-based development of three- and four-antibody cocktails against sars-cov-2 via multiple mechanisms |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005859/ https://www.ncbi.nlm.nih.gov/pubmed/33782529 http://dx.doi.org/10.1038/s41422-021-00497-7 |
| work_keys_str_mv | AT sunyao structurebaseddevelopmentofthreeandfourantibodycocktailsagainstsarscov2viamultiplemechanisms AT wanglei structurebaseddevelopmentofthreeandfourantibodycocktailsagainstsarscov2viamultiplemechanisms AT fengrui structurebaseddevelopmentofthreeandfourantibodycocktailsagainstsarscov2viamultiplemechanisms AT wangnan structurebaseddevelopmentofthreeandfourantibodycocktailsagainstsarscov2viamultiplemechanisms AT wangyuxi structurebaseddevelopmentofthreeandfourantibodycocktailsagainstsarscov2viamultiplemechanisms AT zhudandan structurebaseddevelopmentofthreeandfourantibodycocktailsagainstsarscov2viamultiplemechanisms AT xingxiaorui structurebaseddevelopmentofthreeandfourantibodycocktailsagainstsarscov2viamultiplemechanisms AT yangpeng structurebaseddevelopmentofthreeandfourantibodycocktailsagainstsarscov2viamultiplemechanisms AT zhangyanjun structurebaseddevelopmentofthreeandfourantibodycocktailsagainstsarscov2viamultiplemechanisms AT liweimin structurebaseddevelopmentofthreeandfourantibodycocktailsagainstsarscov2viamultiplemechanisms AT wangxiangxi structurebaseddevelopmentofthreeandfourantibodycocktailsagainstsarscov2viamultiplemechanisms |